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DURING cardiopulmonary bypass (CPB), neutrophils
become activated due to contact with extracorporeal
surfaces and binding of complement fragments C3a and
C5a, leading to extravasation and subsequent tissue
damage. In this study, the effects of the leumedin NPC
15669 (N [9H- (2,7 dimethylfluorenyl 9 methoxy) car
bonyl]-L-leucine), a leukocyte recruitment inhibitor,
were evaluated in a pig model of CPB. NPC 15669 caused
significant inhibition of CPB associated increase in CD18
upregulation, lung tissue myeloperoxidase content, and
percentage wet weight compared to controls. Lung
histology revealed clear airways and minimal neutrophil
infiltration in treated animals vs. significant oedema and
cellular infiltration in controls. It is concluded that CPB
causes a dramatic increase in neutrophil CD18, and that
leumedins are effective in inhibiting neutrophil activation
and subsequent tissue injury when administered during
CPB.
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Introduction
Exposure of blood to extracorporeal artificial
surfaces during procedures such as haemodialysis
or cardiopulmonary bypass (CPB) has been shown
to cause complement activation, resulting in
stimulation of neutrophils.
1-s During CPB, neu-
trophils become sequestered in tissues where they
generate oxygen and hydroxyl free radicals and
release granular constituents such as elastase and
myeloperoxidase (MPO). The effects, seen most
acutely in the lung, can include oedema, tissue
damage, and organ dysfunction. Neutrophil activa-
tion during CPB has been demonstrated
by measuring production of oxygen free radicals
6
and LTB4,
7 release of lactoferrin,8’9 elastase
8-1
and myeloperoxidase,8’11 and increased, formyl-
methionyl-leucyl-phenylalanine (FMLP) receptor
expression,
Although the majority of patients recover
satisfactorily from CPB, there are few effective
means to prevent CPB associated inflammation and
organ injury. Depleting the blood of neutrophils
using leukocyte filters has shown some beneficial
effect in a dog model of CPB. 12 Administration of
steroids can attenuate some effects of complement
mediated neutrophil activation, including neu-
tropenia and chemotaxis, although complement
activation itself may remain unchanged.
13 In
humans, the use of non-steroidal anti-inflammatory
drugs (NSAIDs) in the setting of CPB is
undesirable because of their properties as anti-
coagulants.
In vitro, activation of neutrophils by a variety of
chemotactic factors, including C5a, LTB4, and
FMLP, has been shown to increase the level of
expression of adhesion molecules, mainly the
CDllb/CD18 heterodimer known as Mac-1. Mac-1
is now thought to be the principal molecule
responsible for neutrophil adherence to en-
dothelium.
1-7 In vivo, increased Mac-1 expression
has been demonstrated in neutrophils of patients
undergoing haemodialysis, a procedure in which
the blood is also exposed to artificial surfaces
extracorporeally. Recently a new anti-inflammatory
compound, leumedin NPC 15669, has shown
efficacy in vivo in several neutrophil mediated
inflammatory responses.8’9 In vitro, NPC 15669
prevented the adherence of activated human
neutrophils to cultured endothelial cells, and also
inhibited upregulation of CD1 lb and CD18, the 0
and fl subunits of Mac-1.2 It was felt that similar
results might be obtained in an animal model of
CPB. Preliminary evidence suggests that NPC
15669 may improve pulmonary function during
CPB by inhibiting changes in arterial oxygen
tension and pulmonary vascular resistance.
21 The
present study was undertaken in pigs to determine
whether (1) CD18, the common / subunit of
neutrophil Mac-l, was up-regulated during CPB;
and (2) administration of NPC 15669 during CPB
could affect CD18 expression and reduce neutrophil
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infiltration and subsequent tissue damage in the
lungs.
Materials and Methods
Surgical manipulation: Piglets weighing 10-12 kg were
premedicated with ketamine (40mg/kg, i.m.)
and anaesthetized with Nembutal (R) (30 mg/kg, i.v.).
A tracheostomy was performed and the pigs
ventilated with 100% oxygen at a tidal volume of
15 ml/kg using a volume-cycled ventilator. PEEP
was set at 5 cm H20 and anaesthesia was maintained
with halothane, 0.5-1.0%. A polyethylene cannula
was placed in the femoral artery for pressure
monitoring and a Swan-Ganz catheter was passed
through the external jugular vein. After median
sternotomy, a polyethylene cannula was placed in
the left atrium for pressure monitoring and blood
sampling. All animals received heparin (300 U/kg,
i.v.). Treated animals (n 5) were given a loading
dose of 10 mg/kg NPC 15669, i.v., over 10 min just
before initiating CPB, followed by a constant
infusion at 6 mg/kg/h. This infusion protocol
resulted in a sustained plasma concentration of
about 30/g/ml (Fig. 1). Control animals (n 5)
received equal volumes of vehicle. CPB was
initiated via cannulae placed in the right atrium and
ascending aorta. A pulmonary artery vent was
placed after initiation of bypass. The bypass circuit
included a Sarns roller pump, a Bentley-10 Plus
bubble oxygenator and a 40/m in-line arterial filter.
The prime consisted of 1200 ml of a mixture of fresh
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FIG. 1. Plasma concentration of NPC 15669 in pigs during and after
CPB. Animals (n 5) were given a loading dose of 10mg/kg over
10 min just before the start of CPB, followed by a constant infusion
.at 6mg/kg/h. A stable plasma concentration of approximately
30/g/ml was achieved using this protocol.
homologous blood and crystalloid in a proportion
calculated to produce a final haematocrit of 25%.
Animals were cooled to 28C. Mean systemic
arterial pressure was maintained at 50-55 mmHg
with pump flows of 80 ml/kg when the temperature
was greater than 32C, and 50 ml/kg when the
temperature was less than 32C. Animals were
warmed to 37C during the final 30 min of CPB.
At the conclusion of 2 h of CPB, an isoproterenol
infusion (0.1/g/kg/min) was started and the
animals were weaned from bypass. The animals
were stabilized over the next 30 min, and
isoproterenol was discontinued. Animals were
followed for 2 h after CPB. At the conclusion of
this period, fully anaesthetized animals were
sacrificed by intravenous iniection of KC1. Sections
of the lungs were removed for assessment
of myeloperoxidase content and histological
evaluation.
All animals received humane care in compliance
with the Guide for the Care and Use of Laboratory
Animals published by the National Institutes of
Health.
Antibodies: Antibody to porcine CD18 was the
generous gift of Dr James E. K. Hildreth of Johns
Hopkins Hospital.
22 Antibodies were produced
from a murine hybridoma cell line, and were in the
form of cell culture supernatant. Fluorescein-
conjugated goat anti-mouse immunoglobulin
(FITC-GAMIg) was purchased from Sigma.
Measurement of neutrophil CD18" For in vitro measure-
ments, venous blood was obtained from a
heparinized normal pig. Equal volumes (100/1
each) of whole blood and Hepes buffered Hank’s
balanced salt solution without calcium or magnesi-
um (HHBSS-) with or without NPC 15669 (final
concentration 100/M), were incubated at room
temperature for 15 min. Appropriate samples were
treated with complement component C5a (Sigma),
final concentration 0.5-20 nM, diluted in buffer
containing calcium (HHBSS) at 37C for 20 min.
Samples were then placed on ice and incubated with
anti-porcine CD18 antibody (undiluted, 100/1)
followed by labelling with FITC-GAMIg. After
washing, erythrocytes were lysed and leukocytes
fixed using the Coulter Whole Blood Lysing
Reagent Kit (Coulter Electronics Inc., Hialeah, FL,
USA). Flow cytometric analysis of cellular
fluorescence was performed on a Coulter Profile I1.
Neutrophils were gated on the basis of forward and
90 light scatter, and fluorescence was measured
on a linear scale. Fluorescence values were
converted to percentage increase over control, and
expressed as mean S.E.M.
For measurements during CPB, arterial blood
samples were obtained at the following time points"
pre-sternotomy, post-sternotomy, 15, 60, 90, and
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120 min after initiation of CPB, .and 30, 60, 90 and
120 min post-CPB. Duplicate 100/1 samples were
added to polypropylene tubes on ice and 100 #1
anti-porcine CD18 antibody was added. Samples
were further processed as detailed above. Flow
cytometric analysis of cellular fluorescence was
performed similarly.
Measurement ofplasma NPC 15669 concentration: At the
time points indicated above, arterial blood was
collected and centrifuged at 3 000 g for 15 min,
and the plasma removed. Plasma samples were
stored at -70C until ready for use. An equal
volume of ice-cold ethanol was added to the plasma,
vortex mixed, and then incubated on ice for 10 min.
Each tube was vortex mixed again and centrifuged
for 2 min in a microcentrifuge, then 100 #1 was
iniected onto a Regis SPS-C8 HPLC column,
25 cm 4.6 mm. The ultraviolet absorbing plasma
components elute near the solvent front and the
compound is retained and elutes later. An HP 1040
with diode array detector was used; mobile phase
was 55% acetonitrile in 0.1% TFA, at a flow rate
of 1 ml/min. Detection was at 265 nm. Using this
system, retention time of the internal standard was
11 min, and NPC 15669, 13 min. Standard curves
of NPC 15669 were constructed using spiked
plasma samples.
Measurement of lung tissue myeloperoxidase Lung biopsies
(200 mg) were placed into 2 ml 0.5% hexyldecyl-
trimethylammonium bromide in 50 mM potassium
phosphate, pH 6.0. Tissues were then homogenized
using a Polytron (Brinkmann) for 30 s at a setting
of 6.5. The tissue was then sonicated using a Kontes
Ultrasonic Cell Disrupter with a 3 mm probe.
Finally, the tissue was put through three freeze (dry
ice/methanol)-thaw (37C water bath) cycles. The
disrupted tissue was then centrifuged at 42 000 g
for 15min at 4C. Aliquots (0.1 ml) of the
supernatant were added to 2.9ml assay buffer
(0.167 mg/ml 0-dianisidine, 0.05% hydrogen per-
oxide, 50/M potassium phosphate, pH 6.0).
Absorbance at 460 nm was measured after a 2 min
incubation and converted to /mol/10mg tissue
using an extinction coefficient of 1.13 104 for
oxidized dianisidine.
Histology: Perfusion fixed samples of lung tissue from
five control and five treated animals were processed
for haematoxylin and eosin staining and histologic
examination. Samples from each lobe of the left
lung (total five samples per lung, ten fields each)
were examined under low (25 x power.
Determination of lung tissue percentage, wet weights: After
sacrifice, a 10-20 mg section of the right lung was
removed. The tissue was weighed and then
incubated at 100C for 24 h, after which it was
weighed again. Percentage lung wet weight was
calculated as follows"
percentage wet weight
(wet weight dry weight)/wet weight x 100
Plasma neutrophil counts: Arterial blood samples for
determination of complete blood counts were
drawn at the indicated times. Complete blood
counts were performed by Coulter Counter and
differential cell counts were done manually. Counts
are expressed as mean +_ S.E.M. (n 5).
Statistical analysis" All values are expressed as
mean S.E.M. Significance was determined using
Student’s t-test. Comparison between groups was
made using ANOVA (analysis of variance for
repeated measures).
Results
Inhibition of CD18 upregulation in vitro: Because
neutrophil activation during CPB is associated with
complement activation, the C5a mediated increase
was measured in CD18 on porcine neutrophils in
vitro, and the ability of NPC 15669 to inhibit this
increase was assessed. The results are shown in Fig.
2. Over the given concentration range, human C5a
caused an increase in CD18 expression approx-
imately 40% over control. In previous studies,
2 it
was found that 100/M NPC 15669 caused nearly
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FIG. 2. NPC 15669 inhibition of C5a mediated increase in CD18
expression in vitro. Buffer (100#1 HHBSS-) with (O) or without (O)
NPC 15669 (final concentration 100#M), was added to 100#1 of
heparinized blood from a normal pig. After a 15 min incubation at
room temperature, one-tenth volume HHBSS with or without C5a
(final concentration 0.5-20 nM) was added. After 20min at 37C,
samples were placed on ice and anti-porcine CD18 antibody or
HHBSS was added to appropriate samples. All samples were then
labelled with FITC-GAMIg. Red blood cells were lysed and leukocytes
fixed prior to measurement of cellular fluorescence. Fluorescence values
were converted to percentage increase over control and expressed as the
mean _+ S.E.M. (n 3). *p < 0.05.
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complete inhibition of stimulated neutrophil
adherence to endothelial cells in vitro (ICs0 30 #M).
Therefore, NPC 15669 at this concentration was
tested for its ability to inhibit C5a mediated CD18
upregulation. As shown in Fig. 2, pretreatment of
cells with 100/M NPC 15669 resulted in CD18
expression of just 20% above baseline. In the
range of 1-10nM C5a, this inhibition was
statistically significant (p < 0.05). A similar inhibi-
tion of CD18 expression has been observed
when stimulated human neutrophils are pretreated
with equivalent concentrations of NPC 15669.
20
At this concentration of NPC 15669, neutrophils
are >99% viable, as determined by LDH release
and trypan blue exclusion. Furthermore, the
absence of toxic effects of NPC 15669 in vitro has
been demonstrated in wash-out experiments. When
neutrophils are incubated with 100 #M NPC 15669
for 20 min and then washed free of drug, cellular
activation, as demonstrated by homotypic ag-
gregation and adherence to endothelium, can be
induced by a variety of chemotactic factors (data
not shown).
CD18 expression on neutrophils during CPB: The
expression of CD18, the /J subunit of the Mac-1
adhesion molecule, on neutrophils of five pigs
receiving NPC 15669 and five pigs receiving vehicle
alone was measured. The results are displayed in
Fig. 3. In pigs receiving vehicle, CD18 expression
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FIG. 3. NPC 15669 inhibition of increase in CD18 expression on
neutrophils during CPB. Five piglets received NPC 15669 just prior
to and during CPB (C), 10 mg/kg bolus followed by 6 mg/kg/h i.v.),
and five received vehicle alone (O). Arterial blood samples were
obtained at time points indicated. Anti-porcine CD18 antibody or
buffer was added to 100#1 aliquots of whole blood and incubated
on ice for 30 min. All samples were then labelled with FITC-GAMIg.
Red cells were lysed and leukocytes fixed prior to measurement of
cellular fluorescence. Fluorescence was measured on a linear scale.
Values were converted to percentage increase over baseline and
expressed as mean _+ S.E.M. (n 5 for each group). CD18 expression
in the treated group was significantly less than that in the untreated
group (p < 0.02, ANOVA for repeated measures).
began to increase after sternotomy and continued
to rise throughout bypass to a level greater than
150% over baseline. CD18 expression remained
elevated for the duration of the study (2h
post-bypass). In pigs treated with NPC 15669,
however, CD18 expression was significantly less
than in untreated controls. While CD18 expression
in control animals continued to rise during the 2 h
of bypass, that from leumedin treated animals
plateaued at just 30-50% above baseline during the
same time period. CD18 expression on leumedin
treated pigs increased somewhat after bypass;
however, expression was still significantly lower
than in untreated controls (ANOVA, p < 0.02).
Myeloperoxidase levels in lung tissue" Myeloperoxidase
(MPO) is released from primary (azurophilic)
granules of activated neutrophils. Measurement of
tissue MPO content therefore allows an accurate
assessment of the degree of neutrophil infiltration.
23
Myeloperoxidase was measured in lung tissue
sections taken after each animal was sacrificed. In
normal pigs, lung tissue MPO was determined to
be 16 +__ 3 #tool/10 mg tissue (n 3). In untreated
pigs that underwent CPB, tissue MPO increased
more than six-fold to 106 __+ 9 mol/10 mg tissue.
In pigs treated with NPC 15669, however, lung
tissue MPO increased only three-fold to 48 _-q-4
mol/mg tissue (p 0.0004, n 5 in each group).
These results imply that neutrophil infiltration into
the lungs was significantly inhibited in pigs given
NPC 15669 during bypass.
Lung tissue percentage wet weights" The percentage wet
weight reflects the relative fluid content of the lung
tissue. Thus, an increase in percentage wet weight
indicates oedema. The wet weight of normal lung
tissue was determined to be about 84%. In untreated
animals, this value increased to 88.7-t-0.4% 2 h
post-bypass. In animals pre-treated with NPC
15669, however, the percentage wet weight
increased to just 85.4 q- 0.8, a value significantly less
than in untreated controls (p < 0.03, n 5 in each
group). These results indicate that NPC 15669
prevented the CPB-associated lung oedema ob-
served in untreated animals.
Lung histology: Histological observation of lung tissue
biopsies revealed a striking difference between
treated and untreated animals. Sections of lung
from each animal in both groups were examined.
Representative sections are shown in Fig. 4(a) and
(b). In animals given NPC 15669, pulmonary
structure was virtually normal with little or no
oedema and few sequestered neutrophils. The
alveolar septae are thin and the alveolar spaces
appear clear (Fig. 4a). In contrast, lungs from
untreated animals revealed multi-focal areas of
pulmonary oedema, including interstitial and
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FIG. 4. (a) Photomicrograph of a representative lung section taken
from a pig given NPC 15669 during CPB. The normal lung
architecture is intact. The alveolar septae are thin and the alveolar
spaces appear empty (haematoxylin and eosin, magnification 25);
(b) Photomicrograph of a representative lung section taken from
non-treated animal. The normal alveolar architecture is obscured. The
alveolar spaces are filled with oedema fluid and individual alveolar
spaces cannot be identified (haematoxylin and eosin, 25 ).
intra-alveolar oedema and haemorrhage. In addi-
tion, clusters of red blood cells were evident in the
alveolar spaces, and interstitial capillaries contained
many clusters of neutrophils (Fig. 4b).
Circulating neutrophil counts: In both control and
leumedin treated pigs, circulating neutrophil counts
decreased from approximately 8000/mm pre-
sternotomy to less than 500/mm
3 90min after
initiation of CPB (Fig. 5). However, both lung
MPO content and histological evaluation indicate
that the number of neutrophils sequestered in the
lung tissue was much greater in control than in
treated animals. Thus, the low numbers of
circulating neutrophils in the leumedin treated
group may be a reflection of marginated, rather than
extravasated neutrophils (see Discussion). Un-
treated animals remained neutropenic for the
duration of the post-bypass observation period
(2h). In treated animals, however, neutrophil
counts increased to over 2 000/mm at 2h
post-bypass 0.06), indicating a trend toward
reversal of leukopenia in the treated group.
Discussion
The in vivo anti-inflammatory activity of NPC
15669 has recently been reported. These results
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FIG. 5. Plasma neutrophil counts from control (O) and NPC 15669
treated (C)) animals. Arterial blood samples for determination of
complete blood counts were drawn at the indicated times. Neutrophil
numbers were determined manually from blood smears. Counts are
expressed as mean _+ S.E.M. (n 5).
suggested that NPC 15669 might offer protection
from neutrophil mediated lung injury during CPB.
Therefore, the purposes of this study were (1) to
demonstrate that neutrophil adhesion molecules
were upregulated during CPB in a porcine model;
and (2) to determine whether the anti-inflammatory
compound NPC 15669 could inhibit neutrophil
adhesion molecule upregulation in pigs during
CPB, thereby reducing the neutrophil mediated
tissue injury that often accompanies CPB. It was
demonstrated that CD18 expression increases more
than 150% during porcine CPB, and remains
elevated up to 2 h post-CPB. When NPC 15669 was
administered to pigs during CPB, inhibition of
neutrophil CD18 upregulation was observed. In
contrast to the increase of over 150% in control
animals, less than 50% increase was observed in
animals given NPC 15669. Post-CPB, CD18
expression in leumedin treated animals increased
somewhat; however, it was still significantly less
than that in control animals at all measured
timepoints. Based on these results and those from
previous in vitro neutrophil adherence assays, it is
concluded that inhibition of CD18 expression
contributed to a reduction of neutrophil infiltration
into lung tissue.
Although two f12 integrins, LFA-1 (CDlla/
CD18) and Mac-1 (CDllb/CD18), contribute to
neutrophil adhesion, only Mac-1 expression in-
creases upon stimulation by chemotactic factors. Lo
and coworkers
16 have shown that treatment of
neutrophils with phorbol dibutyrate (PDB), tumour
necrosis factor (TNF), or C5a caused little to no
change in the expression of LFA-1. In contrast,
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Mac-1 expression increased by 150%, 100%, and
50% upon stimulation with PDB, TNF, and C5a,
respectively. While the expression of a third /32
integrin, gp150,95 (CDllc/CD18), has been shown
to increase upon stimulation, its contribution to
neutrophil adhesion is relatively insignificant.24’5 In
the present experiments, use of an antibody to only
the common fl subunit CD18 does not permit
differentiation among LFA-1, Mac-l, and gp150,95
expression. However, previous studies indicated
that NPC 15669 could completely block neutrophil
adherence,e an event mediated by only LFA-1 and
Mac-1. It is conceivable, therefore, that NPC 15669
affects all three /32 integrins, either by inhibiting
upregulation, or by inhibiting other as yet
undefined qualitative alterations in the receptor.
In other animal models
26-28 administration of
monoclonal antibodies against CD18 has been
shown to block neutrophil mediated reperfusion
injury. Unfortunately, it was not possible to test
anti-CD18 antibodies in this model of CPB because
sufficient quantities of anti-porcine CD18 were not
available. However, NPC 15669 has been compared
to anti-integrin antibodies in a model of LPS
mediated endotoxin challenge in mice. 29 In this
model, untreated animals become irreversibly
leukopenic, and death results from organ failure
following neutrophil sequestration in the tissues. In
mice given a lethal dose of LPS (50 mg/kg), NPC
15669 was comparable to anti-CD11b and CD18
antibodies in its ability to improve survival and
reverse neutropenia.
Lung histology indicated that neutrophil seques-
tration was inhibited by NPC 15669. This was
substantiated by measurement of lung tissue MPO
content 2 h post-CPB. In leumedin treated animals,
MPO content was reduced by more than 50%
compared to controls, indicating significant inhibi-
tion of neutrophil infiltration.
The percentage wet weight in end-point lung
biopsies was also determined. The results indicate
that control pigs undergoing CPB develop
considerable lung oedema. NPC 15669 administered
to pigs during CPB largely prevented the oedema
seen in control pigs. Histological evaluation of lung
biopsies confirmed marked oedema in untreated
pigs. In contrast, lung sections from animals
receiving NPC 15669 showed unobstructed airways
and the absence of oedema. It is clear that NPC
15669 exerted a marked effect in inhibiting the
neutrophil accumulation, oedema, and subsequent
tissue injury associated with CPB.
Neutropenia often occurs during CPB. 4’5 In the
pig model described here, very few circulating
neutrophils were present during CPB in both
control and leumedin treated animals. Similarly,
when leumedins were tested in a murine model of
LPS induced leukopenia, both control and treated
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animals were initially neutropenic;
19 however,
neutropenia was dose dependently reversed in
leumedin treated animals over the course of about
24h. Thus in the present study, the initial
neutropenia, as well as the trend toward recovery
from neutropenia during the 2h post-bypass
period, was consistent with earlier observations in
the murine model. Since tissue MPO content in
leumedin treated animals was significantly less than
in untreated controls, the apparent neutropenia
does not necessarily imply neutrophil extravasa-
tion. It is possible that during CPB, the majority of
neutrophils were marginated, that is, slowly rolling
or moderately adherent to endothelial cells lining
the vessels. This loose adherence could be mediated
by the LECAM-1 adhesion molecule, which is
constitutively expressed,
3 rather than by Mac-l,
which is upregulated upon neutrophil activation.
In summary, this study has demonstrated that
neutrophil CD18 expression is upregulated during
CPB. This, combined with other less well
understood activation events, likely leads directly
to increased neutrophil adherence to endothelium,
infiltration into extravascular space, and tissue
injury resulting from release of granular con-
stituents and generation of oxygen derived free
radicals. The novel anti-inflammatory compound
NPC 15669, when given to pigs during CPB,
offered significant protection from the damaging
effects by inhibiting neutrophil activation. This
inhibition was demonstrated by a reduction in
neutrophil CD18 expression, lung tissue myeloper-
oxidase content, and percentage wet weight.
Histological evidence confirmed a marked reduc-
tion in the numbers of infiltrating neutrophils in
the lung. Leumedins may offer significant therapeu-
tic potential in cardiopulmonary bypass and in other
clinical situations where neutrophil mediated tissue
injury is known to occur.
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